Abstract: A method and composition for treating cancer comprising administering to a patient an effective amount of attenuated Salmonella typhimurium containing a plasmid carrying the coding sequence encoding a truncated human interleukin-2 and optionally an oil containing a high antioxidant concentration.
Type:
Grant
Filed:
June 15, 2012
Date of Patent:
February 11, 2014
Assignee:
Cureium Therapeutics LLC
Inventors:
Arnold S. Leonard, Daniel A. Saltzman, Mark J. Mueller